Feel Good Labs Sport Recovery

Description

The product is identified by the SPL code 34089-3. No additional specific description details are provided in the available text.

Uses and Indications

This drug is indicated for the temporary relief of minor aches and pains of the muscles and joints associated with arthritis and simple backache.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

For adults and children aged 2 years and older, the recommended application is to the affected area not more than 3 to 4 times daily. It is important to ensure that the application is limited to the specified frequency to avoid potential adverse effects.

For children under 2 years of age, it is advised to consult a physician prior to use to determine the appropriate course of action and ensure safety.

Contraindications

Application to wounds or damaged skin is contraindicated due to the potential for adverse reactions.

Ingestion of the product is contraindicated; if swallowed, a physician should be consulted immediately.

Tight bandaging is also contraindicated, as it may lead to complications.

Warnings and Precautions

The product is intended for external use only. Healthcare professionals should advise patients to avoid contact with the eyes to prevent irritation or injury. In cases where symptoms persist beyond seven days, it is imperative to discontinue use and consult a physician for further evaluation and management.

Application of the product should be avoided on wounds or damaged skin to prevent adverse effects. Additionally, patients should be cautioned against applying the product with tight bandages, as this may lead to complications.

For individuals who are pregnant or breastfeeding, it is essential to consult a physician prior to use to ensure safety for both the patient and the child.

In the event of accidental ingestion, immediate medical assistance should be sought. If symptoms persist for more than seven days, patients are advised to discontinue use and contact their healthcare provider for further guidance.

Side Effects

Patients should be aware of several important warnings associated with the use of this product. It is intended for external use only, and contact with the eyes should be avoided. In the event that symptoms persist for more than seven days, patients are advised to discontinue use and consult a physician.

To ensure safety, the product should be kept out of reach of children. If swallowed, it is imperative to consult a physician immediately. Additionally, the product should not be applied to wounds or damaged skin, and it is recommended that patients avoid bandaging the area tightly.

For those who are pregnant or breastfeeding, it is essential to consult a physician prior to use to ensure safety for both the patient and the child.

Drug Interactions

No drug interactions or drug and laboratory test interactions have been identified in the available data. Therefore, no specific recommendations for dosage adjustments or monitoring are necessary at this time.

Packaging & NDC

Below are the non-prescription pack sizes of Feel Good Labs Sport Recovery (menthol). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients aged 2 years and older may apply the medication to the affected area up to 3 to 4 times daily. For children under 2 years of age, it is recommended to consult a physician prior to use.

Geriatric Use

There is no specific information regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. Monitoring for potential adverse effects and therapeutic efficacy is recommended in this population.

Pregnancy

Pregnant patients and those who are breastfeeding should consult their physician prior to using this medication. The potential risks and benefits must be carefully evaluated in these populations to ensure the safety of both the mother and the fetus. It is essential for healthcare providers to consider individual circumstances and available data when advising women of childbearing potential regarding the use of this medication during pregnancy and lactation.

Lactation

Lactating mothers are advised to consult their physician prior to using this medication. There is no available data on the excretion of this drug in human breast milk or its effects on breastfed infants. Therefore, healthcare professionals should consider the potential risks and benefits when prescribing this medication to lactating patients.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the available prescribing information. There are no dosage adjustments, special monitoring requirements, or safety considerations outlined for individuals with reduced kidney function. Healthcare professionals should exercise caution and consider the lack of data when prescribing to this patient population.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to this medication. Consequently, there are no dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the prescribing information.

Overdosage

In the event of an overdosage, it is imperative that healthcare professionals take immediate action. If the product is ingested, the individual should be advised to consult a physician without delay.

Potential symptoms of overdosage may vary depending on the specific circumstances and the amount ingested. Therefore, a thorough assessment of the patient's condition is essential.

Management of overdosage should be guided by the severity of symptoms and the clinical judgment of the healthcare provider. It is crucial to monitor the patient closely and provide supportive care as needed. In cases of severe overdosage, further medical intervention may be required, and referral to a poison control center or emergency services should be considered.

Prompt recognition and appropriate management of overdosage can significantly impact patient outcomes.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the understanding of potential risks associated with the compound in nonclinical settings.

Postmarketing Experience

No postmarketing experience details are available in the insert.

Patient Counseling

Healthcare providers should advise patients to consult a physician immediately if the product is swallowed. It is important to emphasize that the product should not be applied to wounds or damaged skin, as this may lead to adverse effects. Additionally, patients should be instructed not to bandage the area tightly after application, as this could interfere with the product's effectiveness and safety.

Storage and Handling

The product is supplied in various package configurations, with specific NDC numbers available for identification. It is essential to store the product at room temperature to maintain its integrity and efficacy. No special handling requirements are necessary beyond standard storage practices.

Additional Clinical Information

The medication is administered topically, with a recommended application frequency of 3 to 4 times daily for adults and children aged 2 years and older. For children under 2 years of age, consultation with a physician is advised prior to use. There is no additional information available regarding laboratory tests, abuse potential, patient counseling, or postmarketing experience.

Drug Information (PDF)

This file contains official product information for Feel Good Labs Sport Recovery, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)